chr16-547040-G-A

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_005632.3(CAPN15):​c.202G>A​(p.Gly68Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000785 in 1,608,598 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00051 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00081 ( 2 hom. )

Consequence

CAPN15
NM_005632.3 missense

Scores

3
9
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.56

Publications

3 publications found
Variant links:
Genes affected
CAPN15 (HGNC:11182): (calpain 15) This gene encodes a protein containing zinc-finger-like repeats and a calpain-like protease domain. The encoded protein may function as a transcription factor, RNA-binding protein, or in protein-protein interactions during visual system development. [provided by RefSeq, Jul 2008]
CAPN15 Gene-Disease associations (from GenCC):
  • oculogastrointestinal-neurodevelopmental syndrome
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.09158483).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000505 (77/152384) while in subpopulation NFE AF = 0.000779 (53/68040). AF 95% confidence interval is 0.000611. There are 0 homozygotes in GnomAd4. There are 37 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAPN15NM_005632.3 linkc.202G>A p.Gly68Ser missense_variant Exon 4 of 14 ENST00000219611.7 NP_005623.1 O75808-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAPN15ENST00000219611.7 linkc.202G>A p.Gly68Ser missense_variant Exon 4 of 14 1 NM_005632.3 ENSP00000219611.2 O75808-1

Frequencies

GnomAD3 genomes
AF:
0.000506
AC:
77
AN:
152266
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000779
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000722
AC:
173
AN:
239604
AF XY:
0.000754
show subpopulations
Gnomad AFR exome
AF:
0.0000659
Gnomad AMR exome
AF:
0.00143
Gnomad ASJ exome
AF:
0.000307
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000545
Gnomad NFE exome
AF:
0.000925
Gnomad OTH exome
AF:
0.000511
GnomAD4 exome
AF:
0.000814
AC:
1186
AN:
1456214
Hom.:
2
Cov.:
32
AF XY:
0.000814
AC XY:
590
AN XY:
724552
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33452
American (AMR)
AF:
0.00162
AC:
72
AN:
44580
Ashkenazi Jewish (ASJ)
AF:
0.000461
AC:
12
AN:
26056
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39644
South Asian (SAS)
AF:
0.000616
AC:
53
AN:
86034
European-Finnish (FIN)
AF:
0.000264
AC:
13
AN:
49158
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5764
European-Non Finnish (NFE)
AF:
0.000894
AC:
993
AN:
1111280
Other (OTH)
AF:
0.000681
AC:
41
AN:
60246
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
74
148
221
295
369
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000505
AC:
77
AN:
152384
Hom.:
0
Cov.:
34
AF XY:
0.000497
AC XY:
37
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41588
American (AMR)
AF:
0.000522
AC:
8
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4834
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000779
AC:
53
AN:
68040
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000841
Hom.:
0
Bravo
AF:
0.000608
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000648
AC:
78

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 30, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.202G>A (p.G68S) alteration is located in exon 4 (coding exon 1) of the CAPN15 gene. This alteration results from a G to A substitution at nucleotide position 202, causing the glycine (G) at amino acid position 68 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.26
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
T;T;T
Eigen
Uncertain
0.56
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.94
D;D;D
M_CAP
Uncertain
0.089
D
MetaRNN
Benign
0.092
T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Uncertain
2.1
.;M;.
PhyloP100
8.6
PrimateAI
Uncertain
0.65
T
PROVEAN
Uncertain
-3.4
D;D;.
REVEL
Uncertain
0.38
Sift
Pathogenic
0.0
D;D;.
Sift4G
Pathogenic
0.0
D;T;.
Polyphen
1.0
.;D;.
Vest4
0.73
MVP
0.46
ClinPred
0.10
T
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.30
gMVP
0.60
Mutation Taster
=46/54
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144165814; hg19: chr16-597040; API